ClinicalTrials.Veeva

Menu

The Efficacy of Probe-based Confocal Laser Endomicroscopy in Staging OLGIM

S

Shandong University

Status

Unknown

Conditions

the Operative Link on Gastric Intestinal Metaplasia
Probe-based Confocal Laser Endomicroscopy

Study type

Observational

Funder types

Other

Identifiers

NCT02932735
2016SDU-QILU-18

Details and patient eligibility

About

Gastric intestinal metaplasia (GIM) is an important premalignant lesion for gastric cancer. Precisely surveillance of patients with GIM may result in early detection and improved prognosis. Though important, it is not necessary to recommend surveillance endoscopy for all patients with GIM, since the progression rate to gastric cancer within 10 years is only 1.8% in those patients.

Enrollment

30 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 40 years or older with Helicobacter pylori infection;
  • Histologically verified GIM, atrophic gastritis or dysplasia.

Exclusion criteria

  • Patients with gastrectomy, acute GI bleeding and advanced gastric cancer;
  • Conditions unsuitable for performance of pCLE, such as coagulopathy, impaired renal function or allergy to fluorescein sodium;
  • Pregnancy or breastfeeding;
  • Inability to provide informed consent and other situations that could interfere with the examination or therapeutic protocol.

Trial contacts and locations

0

Loading...

Central trial contact

Li Yanqing, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems